首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line.
【24h】

Synthesis and antiproliferative activity of indolizine derivatives incorporating a cyclopropylcarbonyl group against Hep-G2 cancer cell line.

机译:结合有环丙基羰基的吲哚嗪衍生物的合成及其抗Hep-G2癌细胞系的活性。

获取原文
获取原文并翻译 | 示例
           

摘要

Indolizine and annulated indolizine derivatives incorporating a cyclopropylcarbonyl group were synthesized in a one pot procedure by the tanden reactions of [3+2] cycloaddition of the corresponding N-ylide with electron deficient alkene. Seventeen indolizine derivatives were reported for the first time. All the compounds were examined for their antiproliferative activity against the human hepatocellular liver carcinoma (Hep-G2) cell line by MTT method. Among the compounds tested, 5a, 5d, 5 g and 5 j showed the most favorable activities with IC(50) values of 0.39, 0.48, 0.29 and 0.20 microg/mL. Especially, compound 5 j displayed potent antiproliferative activities with IC(50) value of 0.20 microg/mL, and showed significant EGFR kinase inhibitory activity with IC(50) value of 0.085 microM. Docking simulations of 5 j were carried out to illustrate the binding mode of the molecular into the EGFR active site.
机译:通过相应的N-内酯的[3 + 2]环加成与电子不足的烯烃的鞣制反应,通过一锅法合成了吲哚并嗪和结合有环丙基羰基的环状吲哚并嗪衍生物。首次报道了十七种吲哚嗪衍生物。通过MTT法检查所有化合物对人肝细胞肝癌(Hep-G2)细胞的抗增殖活性。在测试的化合物中,5a,5d,5 g和5 j表现出最有利的活性,IC(50)值为0.39、0.48、0.29和0.20 microg / mL。特别地,化合物5j显示出有效的抗增殖活性,IC(50)值为0.20 microg / mL,并显示出显着的EGFR激酶抑制活性,IC(50)值为0.085 microM。进行5j的对接模拟以说明分子与EGFR活性位点的结合方式。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号